Literature DB >> 1372506

Tyrosine phosphorylation and its possible role in superoxide production by human neutrophils stimulated with FMLP and IgG.

T Kusunoki1, H Higashi, S Hosoi, D Hata, K Sugie, M Mayumi, H Mikawa.   

Abstract

Superoxide production by human neutrophils stimulated with FMLP and soluble aggregated human IgG were inhibited in a dose dependent manner by two kinds of tyrosine kinase inhibitors, erbstatin and genistein. Superoxide production stimulated with surface bound IgG, however, was scarcely inhibited by either inhibitor. Protein tyrosine phosphorylation studies with immunoblotting revealed specific tyrosine phosphorylation of a 40 Kd protein by soluble aggregated and surface bound IgG, and that of a 39 Kd protein, as well as the 40 Kd protein, by FMLP. These were all inhibited by the tyrosine kinase inhibitors. These data suggest that superoxide production induced by FMLP and soluble aggregated IgG are, at least in part, tyrosine kinase dependent, but the tyrosine kinases and/or substrates of tyrosine kinases involved may be different. In addition, tyrosine kinase independent pathways are also suggested to be involved in superoxide production by stimulation with surface bound IgG.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1372506     DOI: 10.1016/0006-291x(92)90552-v

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Signal transduction mechanism involved in Clostridium perfringens alpha-toxin-induced superoxide anion generation in rabbit neutrophils.

Authors:  Masataka Oda; Syusuke Ikari; Takayuki Matsuno; Yuka Morimune; Masahiro Nagahama; Jun Sakurai
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

2.  The activation of the neutrophil respiratory burst by anti-neutrophil cytoplasm autoantibody (ANCA) from patients with systemic vasculitis requires tyrosine kinases and protein kinase C activation.

Authors:  D J Radford; J M Lord; C O Savage
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

3.  Reactive oxygen species mediate phorbol ester-regulated tyrosine phosphorylation and phospholipase A2 activation: potentiation by vanadate.

Authors:  U Zor; E Ferber; P Gergely; K Szücs; V Dombrádi; R Goldman
Journal:  Biochem J       Date:  1993-11-01       Impact factor: 3.857

4.  Crystal-induced neutrophil activation. IV. Specific inhibition of tyrosine phosphorylation by colchicine.

Authors:  C J Roberge; M Gaudry; R de Médicis; A Lussier; P E Poubelle; P H Naccache
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

5.  Tyrosine phosphorylation and activation of NADPH oxidase in human neutrophils: a possible role for MAP kinases and for a 75 kDa protein.

Authors:  S Dusi; M Donini; F Rossi
Journal:  Biochem J       Date:  1994-11-15       Impact factor: 3.857

6.  Protein tyrosine kinase activity is essential for Fc gamma receptor-mediated intracellular killing of Staphylococcus aureus by human monocytes.

Authors:  L Zheng; P H Nibbering; T P Zomerdijk; R van Furth
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

7.  Influence of arachidonic acid on indices of phospholipase A2 activity in the human neutrophil.

Authors:  J D Winkler; C M Sung; W C Hubbard; F H Chilton
Journal:  Biochem J       Date:  1993-05-01       Impact factor: 3.857

8.  Tyrosine phosphorylation induced by cross-linking of Fc gamma-receptor type II in human neutrophils.

Authors:  L Liang; C K Huang
Journal:  Biochem J       Date:  1995-03-01       Impact factor: 3.857

9.  Adhesion-dependent protein tyrosine phosphorylation in neutrophils treated with tumor necrosis factor.

Authors:  M Fuortes; W W Jin; C Nathan
Journal:  J Cell Biol       Date:  1993-02       Impact factor: 10.539

10.  Prostaglandin cyclooxygenase products but not thromboxane A(2) are involved in the pathogenesis of ewthromelalgia in thrombocythaemia.

Authors:  J J Michiels; F J Zijlstra
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.